Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm– a model to enhance the HCV continuum of care
Abstract Background People with opioid agonist therapy (OAT) represent a population with an increased hepatitis C (HCV) prevalence. Recent studies provide strong evidence regarding effective HCV treatment outcomes and low levels of reinfection in this population. Increased access to HCV care for peo...
Saved in:
| Main Authors: | Per-Erik Klasa, Mikael Sandell, Soo Aleman, Martin Kåberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Psychiatry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12888-025-06733-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm– a model to enhance the HCV continuum of care
by: Per-Erik Klasa, et al.
Published: (2025-07-01) -
Threshold value of the anti-HCV test in the diagnosis of HCV infection
by: Özlem Kirişci, et al.
Published: (2019-10-01) -
The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey
by: Bülent Dabanlıoğlu, et al.
Published: (2024-01-01) -
Performance of Elecsys<sup>®</sup> HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection
by: Prooksa Ananchuensook, et al.
Published: (2024-09-01) -
PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
by: Ana Virseda-Berdices, et al.
Published: (2025-01-01)